Status:
RECRUITING
Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy
Lead Sponsor:
University of Sao Paulo General Hospital
Collaborating Sponsors:
Air Liquide SA
Conditions:
ILD
COPD
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Assess quality of life of patients using prolonged oxygen therapy
Detailed Description
Adult participants of both sexes with COPD and PID, prolonged oxygen use, will be evaluated after being informed about the study, agreeing and signing the informed consent form. Participants will be r...
Eligibility Criteria
Inclusion
- Patients with a clinical, radiological and/or anatomopathological diagnosis of COPD and ILD according to the 2020 ATS/JRS/ALAT guidelines;
- Age over 18 years;
- Clinical stability (absence of exacerbations or hospitalizations related to the underlying disease) for at least 6 weeks;
- Patients who are on optimized drug therapy, including long-term home oxygen therapy (LTOT)
- Have a smartphone compatible with the monitoring device;
- Signing of the ICF to participate in the study.
Exclusion
- Presence of other concomitant lung diseases;
- Myocardial infarction within four months prior to the start of the study, unstable angina or severe heart disease (NYHA functional class III-IV) and/or decompensated.
- Patients who received a lung transplant during the study
- Living outside the coverage area or moving out of state
Key Trial Info
Start Date :
November 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06882265
Start Date
November 10 2024
End Date
December 15 2025
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP),
São Paulo, São Paulo, Brazil, 05360-160